• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinoline carboxylic acids

Introduction to 6-Bromoquinoline-4-carboxylic acid (CAS No. 160233-76-1)

6-Bromoquinoline-4-carboxylic acid (CAS No. 160233-76-1) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique brominated quinoline structure, has shown promise in various applications, including as a potential lead compound for drug development and as a key intermediate in the synthesis of bioactive molecules.

The chemical structure of 6-Bromoquinoline-4-carboxylic acid consists of a quinoline ring with a bromine atom at the 6-position and a carboxylic acid group at the 4-position. This configuration imparts specific physicochemical properties that make it an attractive candidate for further investigation. The bromine substituent enhances the lipophilicity of the molecule, which can influence its biological activity and pharmacokinetic properties. The carboxylic acid group, on the other hand, provides a functional handle for chemical modification and conjugation with other moieties.

In recent years, 6-Bromoquinoline-4-carboxylic acid has been studied extensively for its potential therapeutic applications. One notable area of research is its use as an antimicrobial agent. Quinolines have long been known for their antibacterial properties, and the introduction of a bromine substituent has been shown to enhance these effects. Studies have demonstrated that derivatives of 6-Bromoquinoline-4-carboxylic acid exhibit potent activity against a range of Gram-positive and Gram-negative bacteria, making them promising candidates for the development of new antibiotics.

Beyond antimicrobial applications, 6-Bromoquinoline-4-carboxylic acid has also been explored for its anticancer properties. Research has shown that certain derivatives of this compound can selectively inhibit cancer cell proliferation by targeting specific signaling pathways. For example, a study published in the Journal of Medicinal Chemistry reported that a derivative of 6-Bromoquinoline-4-carboxylic acid exhibited significant cytotoxicity against human breast cancer cells by disrupting the PI3K/AKT signaling pathway. This finding highlights the potential of this compound as a lead molecule for cancer therapy.

In addition to its direct biological activities, 6-Bromoquinoline-4-carboxylic acid serves as an important intermediate in the synthesis of more complex bioactive molecules. Its reactive carboxylic acid group allows for facile derivatization through various chemical reactions, such as esterification, amidation, and coupling with other functional groups. This versatility makes it a valuable building block in the design and synthesis of novel pharmaceuticals and biologically active compounds.

The synthesis of 6-Bromoquinoline-4-carboxylic acid has been optimized through several methods, including classical organic synthesis routes and modern catalytic approaches. One common method involves the bromination of quinoline followed by carboxylation to introduce the carboxylic acid group. Recent advancements in green chemistry have also led to more environmentally friendly synthetic routes that minimize waste and reduce the use of hazardous reagents.

The physicochemical properties of 6-Bromoquinoline-4-carboxylic acid, such as its solubility, stability, and melting point, have been well-characterized through various analytical techniques. These properties are crucial for understanding its behavior in biological systems and optimizing its formulation for pharmaceutical applications. For instance, studies have shown that the compound exhibits good solubility in polar solvents like DMSO and water, which facilitates its use in biological assays and drug delivery systems.

In conclusion, 6-Bromoquinoline-4-carboxylic acid (CAS No. 160233-76-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structure and versatile reactivity make it an attractive candidate for developing new drugs with diverse therapeutic applications. Ongoing research continues to uncover new insights into its biological activities and synthetic methodologies, further solidifying its importance in the field.

• 10406-06-1(5-Bromo-1H-indole-3-carboxylic acid)
• 7101-68-0(4-methylquinoline-6-carboxylic acid)
• 89118-76-3(4,7-Quinolinedicarboxylicacid)
• 204782-96-7(8-Bromo-5-quinolinecarboxylic acid)
• 219763-87-8(4-Bromoquinoline-6-carboxylic acid)
• 798545-30-9(6-Bromoquinoline-3-carboxylic acid)
• 374633-27-9(4-Bromo-1H-indole-6-carboxylic acid)
• 919293-20-2(Benz[h]isoquinoline-6-carboxylic acid, 9-bromo-)
• 121490-67-3(8-Bromoquinoline-4-carboxylic acid)
• 898746-91-3(6-Bromo-1H-indole-4-carboxylic acid)